Showing 1 - 10 of 57
British people are the least supportive nation in their attitude towards driverless cars, or indeed any form of autonomous vehicle (AV), according to a study across six territories (United Kingdom, United States, Australia, China, Singapore and Hong Kong).
As one of the largest studies on attitudes towards autonomous vehicles to date, our new report explores public support across the globe and insights from key industry leaders.
The results of the Law Commission of England and Wales and the Scottish Law Commissions’ joint preliminary consultation into the safe regulation of autonomous vehicles (AVs), echo the importance of manufacturers working collaboratively with government and insurers on data management in the new driverless vehicles environment.
In this article we explore the ramifications of business interruption, the legal framework relating to business interruption and how, through business continuity planning, those issues can be managed.
Courts differ on the issue of allocation to the insured for periods in which coverage was unavailable
Claims involving multi-year losses under occurrence-based policies often raise questions as to whether an insured must participate in allocation for periods in which the insured was without coverage.
Early March 2019 marked the second annual #GenomicsConversation Week, the Genomics Education Programme’s annual week of action for all health professionals. The goal of this NHS initiative is to encourage conversation and awareness among all health professionals and to help them feel more comfortable discussing genomic testing with patients.
The government needs to do much more to bring stakeholders together if it is to successfully implement autonomous vehicles (AVs) in the UK, we have told the Law Commission’s consultation on the introduction of AVs in the UK.
Good news for businesses and customers as proposed Brexit legislation provides for evolution, not revolution, of the current construction products performance regime.
Artificial intelligence is prevalent across many areas of our day-to-day life and now increasingly so in medical products. This article focuses on the potential liability issues for such products, particularly in the healthcare sector.
Case review 01/18/2019
The New South Wales Supreme Court of Appeal has handed down its decision in the matter of Mobis Parts Australia Pty Ltd v XL Insurance Company SE  NSWCA 342. The decision provides authority in relation to the equitable remedy of rectification, the common-law test for loss and costs.